BMY logo

Bristol-Myers Squibb Company (BMY) Cash From Investing

Annual CFI:

-$21.35B-$19.06B(-830.37%)
December 31, 2024

Summary

  • As of today, BMY annual cash from investing is -$21.35 billion, with the most recent change of -$19.06 billion (-830.37%) on December 31, 2024.
  • During the last 3 years, BMY annual cash from investing has fallen by -$20.81 billion (-3868.77%).
  • BMY annual cash from investing is now -520.40% below its all-time high of $5.08 billion, reached on December 31, 2008.

Performance

BMY Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYcash flow metrics

Quarterly CFI:

-$473.00M+$26.00M(+5.21%)
June 30, 2025

Summary

  • As of today, BMY quarterly cash from investing is -$473.00 million, with the most recent change of +$26.00 million (+5.21%) on June 30, 2025.
  • Over the past year, BMY quarterly cash from investing has increased by +$846.00 million (+64.14%).
  • BMY quarterly cash from investing is now -111.95% below its all-time high of $3.96 billion, reached on September 30, 2008.

Performance

BMY Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYcash flow metrics

TTM CFI:

-$1.39B+$846.00M(+37.89%)
June 30, 2025

Summary

  • As of today, BMY TTM cash from investing is -$1.39 billion, with the most recent change of +$846.00 million (+37.89%) on June 30, 2025.
  • Over the past year, BMY TTM cash from investing has increased by +$21.31 billion (+93.89%).
  • BMY TTM cash from investing is now -127.31% below its all-time high of $5.08 billion, reached on December 31, 2008.

Performance

BMY TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

BMY Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-830.4%+64.1%+93.9%
3Y3 Years-3868.8%-63.7%-80.4%
5Y5 Years-118.5%-160.6%+87.1%

BMY Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-3868.8%at low-139.0%+97.6%-625.4%+93.9%
5Y5-Year-3868.8%at low-139.0%+97.6%-625.4%+93.9%
All-TimeAll-Time-520.4%at low-112.0%+97.6%-127.3%+93.9%

BMY Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$473.00M(+5.2%)
-$1.39B(+37.9%)
Mar 2025
-
-$499.00M(-154.6%)
-$2.23B(+89.5%)
Dec 2024
-$21.35B(-830.4%)
-$196.00M(+10.5%)
-$21.35B(+5.1%)
Sep 2024
-
-$219.00M(+83.4%)
-$22.50B(+0.8%)
Jun 2024
-
-$1.32B(+93.3%)
-$22.69B(-4.6%)
Mar 2024
-
-$19.62B(-1357.5%)
-$21.70B(-845.7%)
Dec 2023
-$2.29B(-116.1%)
-$1.35B(-228.3%)
-$2.29B(-969.3%)
Sep 2023
-
-$410.00M(-24.6%)
$264.00M(+118.8%)
Jun 2023
-
-$329.00M(-56.7%)
-$1.41B(-2.9%)
Mar 2023
-
-$210.00M(-117.3%)
-$1.37B(-28.7%)
Dec 2022
-$1.06B(-97.4%)
$1.21B(+158.3%)
-$1.06B(+43.3%)
Sep 2022
-
-$2.08B(-620.1%)
-$1.87B(-143.7%)
Jun 2022
-
-$289.00M(-404.2%)
-$769.00M(-156.3%)
Mar 2022
-
$95.00M(-76.3%)
-$300.00M(+44.2%)
Dec 2021
-$538.00M(+95.0%)
$401.00M(+141.1%)
-$538.00M(+95.9%)
Sep 2021
-
-$976.00M(-642.2%)
-$13.07B(-6.6%)
Jun 2021
-
$180.00M(+225.9%)
-$12.26B(-5.1%)
Mar 2021
-
-$143.00M(+98.8%)
-$11.65B(-7.3%)
Dec 2020
-$10.86B(-11.1%)
-$12.13B(-7249.7%)
-$10.86B(-0.8%)
Sep 2020
-
-$165.00M(-121.2%)
-$10.77B(-6.5%)
Jun 2020
-
$780.00M(+19.4%)
-$10.11B(+0.6%)
Mar 2020
-
$653.00M(+105.4%)
-$10.18B(-4.2%)
Dec 2019
-$9.77B(-1017.8%)
-$12.04B(-2551.3%)
-$9.77B(-606.2%)
Sep 2019
-
$491.00M(-31.3%)
$1.93B(+49.4%)
Jun 2019
-
$715.00M(-32.5%)
$1.29B(+464.2%)
Mar 2019
-
$1.06B(+415.5%)
$229.00M(+126.2%)
Dec 2018
-$874.00M(-1224.2%)
-$336.00M(-128.6%)
-$874.00M(-281.7%)
Sep 2018
-
-$147.00M(+57.8%)
$481.00M(-37.5%)
Jun 2018
-
-$348.00M(-709.3%)
$770.00M(+719.1%)
Mar 2018
-
-$43.00M(-104.2%)
$94.00M(+242.4%)
Dec 2017
-$66.00M(-104.5%)
$1.02B(+617.6%)
-$66.00M(+93.8%)
Sep 2017
-
$142.00M(+113.9%)
-$1.07B(+32.3%)
Jun 2017
-
-$1.02B(-404.4%)
-$1.58B(-959.7%)
Mar 2017
-
-$203.00M(-1368.8%)
-$149.00M(-110.1%)
Dec 2016
$1.48B(+194.1%)
$16.00M(+104.3%)
$1.48B(+208.3%)
Sep 2016
-
-$368.00M(-190.6%)
$480.00M(-38.9%)
Jun 2016
-
$406.00M(-71.5%)
$786.00M(+187.3%)
Mar 2016
-
$1.43B(+244.9%)
-$900.00M(+42.7%)
Dec 2015
-$1.57B(-229.3%)
-$984.00M(-1487.1%)
-$1.57B(-563.3%)
Sep 2015
-
-$62.00M(+95.2%)
-$237.00M(-2054.5%)
Jun 2015
-
-$1.28B(-269.8%)
-$11.00M(+95.5%)
Mar 2015
-
$754.00M(+114.8%)
-$242.00M(-119.9%)
Dec 2014
$1.22B(+312.6%)
$351.00M(+114.0%)
$1.22B(+121.1%)
Sep 2014
-
$164.00M(+110.9%)
$550.00M(+718.0%)
Jun 2014
-
-$1.51B(-168.3%)
-$89.00M(-106.0%)
Mar 2014
-
$2.21B(+802.2%)
$1.48B(+358.6%)
Dec 2013
-$572.00M(+91.5%)
-$315.00M(+33.7%)
-$572.00M(-2960.0%)
Sep 2013
-
-$475.00M(-933.3%)
$20.00M(+100.5%)
Jun 2013
-
$57.00M(-64.6%)
-$3.71B(-4.8%)
Mar 2013
-
$161.00M(-41.9%)
-$3.54B(+47.4%)
Dec 2012
-$6.73B(-368.1%)
$277.00M(+106.6%)
-$6.73B(-3.3%)
Sep 2012
-
-$4.20B(-1959.7%)
-$6.51B(-163.6%)
Jun 2012
-
$226.00M(+107.5%)
-$2.47B(+18.4%)
Mar 2012
-
-$3.03B(-711.5%)
-$3.03B(-110.6%)
Dec 2011
-$1.44B(+62.3%)
$495.00M(+403.7%)
-$1.44B(+67.4%)
Sep 2011
-
-$163.00M(+50.9%)
-$4.41B(-33.7%)
Jun 2011
-
-$332.00M(+76.9%)
-$3.30B(-20.9%)
Mar 2011
-
-$1.44B(+42.0%)
-$2.73B(+28.4%)
Dec 2010
-$3.81B(+13.0%)
-$2.48B(-361.5%)
-$3.81B(-61.5%)
Sep 2010
-
$948.00M(+298.3%)
-$2.36B(+55.4%)
Jun 2010
-
$238.00M(+109.4%)
-$5.30B(+11.3%)
Mar 2010
-
-$2.52B(-145.3%)
-$5.97B(-36.4%)
Dec 2009
-$4.38B(-186.2%)
-$1.03B(+48.4%)
-$4.38B(-92.2%)
Sep 2009
-
-$1.99B(-354.1%)
-$2.28B(-162.1%)
Jun 2009
-
-$438.00M(+52.7%)
$3.67B(+2.5%)
Mar 2009
-
-$926.00M(-186.2%)
$3.58B(-29.5%)
Dec 2008
$5.08B(+2614.4%)
$1.07B(-72.9%)
$5.08B(+25.7%)
Sep 2008
-
$3.96B(+852.7%)
$4.04B(+752.1%)
Jun 2008
-
-$526.00M(-192.0%)
$474.00M(+30.6%)
Mar 2008
-
$572.00M(+1582.4%)
$363.00M(+279.7%)
Dec 2007
-$202.00M(-198.1%)
$34.00M(-91.4%)
-$202.00M(-140.1%)
Sep 2007
-
$394.00M(+161.9%)
$504.00M(>+9900.0%)
Jun 2007
-
-$637.00M(-9200.0%)
-$2.00M(-100.4%)
Mar 2007
-
$7.00M(-99.1%)
$490.00M(+137.9%)
Dec 2006
$206.00M
$740.00M(+760.7%)
$206.00M(+111.1%)
Sep 2006
-
-$112.00M(+22.8%)
-$1.86B(-11.7%)
DateAnnualQuarterlyTTM
Jun 2006
-
-$145.00M(+47.7%)
-$1.66B(>-9900.0%)
Mar 2006
-
-$277.00M(+79.1%)
-$15.00M(-101.3%)
Dec 2005
$1.19B(+173.4%)
-$1.32B(-1713.4%)
$1.19B(-50.4%)
Sep 2005
-
$82.00M(-94.5%)
$2.40B(+30.6%)
Jun 2005
-
$1.50B(+61.8%)
$1.84B(+2143.3%)
Mar 2005
-
$929.00M(+922.1%)
-$90.00M(+94.5%)
Dec 2004
-$1.62B(+32.9%)
-$113.00M(+76.5%)
-$1.62B(+48.6%)
Sep 2004
-
-$480.00M(-12.7%)
-$3.16B(-9.4%)
Jun 2004
-
-$426.00M(+29.4%)
-$2.89B(-4.6%)
Mar 2004
-
-$603.00M(+63.4%)
-$2.76B(-14.1%)
Dec 2003
-$2.42B(-19.2%)
-$1.65B(-692.8%)
-$2.42B(-38.3%)
Sep 2003
-
-$208.00M(+30.4%)
-$1.75B(+6.7%)
Jun 2003
-
-$299.00M(-13.7%)
-$1.87B(-10.0%)
Mar 2003
-
-$263.00M(+73.1%)
-$1.70B(+16.1%)
Dec 2002
-$2.03B(+58.3%)
-$979.00M(-194.0%)
-$2.03B(-200.5%)
Sep 2002
-
-$333.00M(-158.1%)
$2.02B(+139.1%)
Jun 2002
-
-$129.00M(+78.1%)
-$5.16B(-0.3%)
Mar 2002
-
-$589.00M(-119.2%)
-$5.14B(-5.7%)
Dec 2001
-$4.86B(>-9900.0%)
$3.07B(+140.9%)
-$4.86B(+41.2%)
Sep 2001
-
-$7.51B(-6669.4%)
-$8.27B(-1917.1%)
Jun 2001
-
-$111.00M(+64.2%)
-$410.00M(-2.8%)
Mar 2001
-
-$310.00M(+7.5%)
-$399.00M(-2593.8%)
Dec 2000
$16.00M(+102.1%)
-$335.00M(-196.8%)
$16.00M(+166.7%)
Sep 2000
-
$346.00M(+446.0%)
$6.00M(+101.4%)
Jun 2000
-
-$100.00M(-195.2%)
-$415.00M(+18.3%)
Mar 2000
-
$105.00M(+130.4%)
-$508.00M(+33.1%)
Dec 1999
-$759.00M(-119.4%)
-$345.00M(-360.0%)
-$759.00M(-24.6%)
Sep 1999
-
-$75.00M(+61.1%)
-$609.00M(+13.6%)
Jun 1999
-
-$193.00M(-32.2%)
-$705.00M(-31.0%)
Mar 1999
-
-$146.00M(+25.1%)
-$538.00M(-55.5%)
Dec 1998
-$346.00M(+35.0%)
-$195.00M(-14.0%)
-$346.00M(-15.3%)
Sep 1998
-
-$171.00M(-557.7%)
-$300.00M(+10.7%)
Jun 1998
-
-$26.00M(-156.5%)
-$336.00M(+4.3%)
Mar 1998
-
$46.00M(+130.9%)
-$351.00M(+34.0%)
Dec 1997
-$532.00M(+25.8%)
-$149.00M(+28.0%)
-$532.00M(-18.5%)
Sep 1997
-
-$207.00M(-404.9%)
-$449.00M(-27.6%)
Jun 1997
-
-$41.00M(+69.6%)
-$352.00M(+34.9%)
Mar 1997
-
-$135.00M(-104.5%)
-$541.00M(+24.5%)
Dec 1996
-$717.00M(-13.6%)
-$66.00M(+40.0%)
-$717.00M(+14.2%)
Sep 1996
-
-$110.00M(+52.2%)
-$836.00M(+4.3%)
Jun 1996
-
-$230.00M(+26.0%)
-$874.00M(-29.5%)
Mar 1996
-
-$311.00M(-68.1%)
-$675.00M(-7.0%)
Dec 1995
-$631.00M(+55.7%)
-$185.00M(-25.0%)
-$631.00M(+9.6%)
Sep 1995
-
-$148.00M(-377.4%)
-$698.00M(+50.5%)
Jun 1995
-
-$31.00M(+88.4%)
-$1.41B(+9.6%)
Mar 1995
-
-$267.00M(-6.0%)
-$1.56B(-9.6%)
Dec 1994
-$1.42B(-138.5%)
-$252.00M(+70.7%)
-$1.42B(-8.1%)
Sep 1994
-
-$861.00M(-378.3%)
-$1.32B(-153.8%)
Jun 1994
-
-$180.00M(-37.4%)
-$519.00M(-92.2%)
Mar 1994
-
-$131.00M(+9.7%)
-$270.00M(+54.8%)
Dec 1993
-$597.00M(-238.8%)
-$145.00M(-130.2%)
-$597.00M(-223.1%)
Sep 1993
-
-$63.00M(-191.3%)
$485.00M(+37.8%)
Jun 1993
-
$69.00M(+115.1%)
$352.00M(+295.5%)
Mar 1993
-
-$458.00M(-148.9%)
$89.00M(-79.3%)
Dec 1992
$430.00M(-24.7%)
$937.00M(+578.1%)
$430.00M(+169.8%)
Sep 1992
-
-$196.00M(-1.0%)
-$616.00M(-56.7%)
Jun 1992
-
-$194.00M(-65.8%)
-$393.00M(-235.5%)
Mar 1992
-
-$117.00M(-7.3%)
$290.00M(-49.2%)
Dec 1991
$571.00M(+448.2%)
-$109.00M(-503.7%)
$571.00M(+1602.6%)
Sep 1991
-
$27.00M(-94.5%)
-$38.00M(+60.8%)
Jun 1991
-
$489.00M(+198.2%)
-$97.00M(+72.4%)
Mar 1991
-
$164.00M(+122.8%)
-$352.00M(-114.6%)
Dec 1990
-$164.00M(+70.5%)
-$718.00M(-2143.8%)
-$164.00M(-129.6%)
Sep 1990
-
-$32.00M(-113.7%)
$554.00M(-5.5%)
Jun 1990
-
$234.00M(-33.5%)
$586.00M(+66.5%)
Mar 1990
-
$352.00M
$352.00M
Dec 1989
-$555.00M(+87.9%)
-
-
Dec 1988
-$4.60B(>-9900.0%)
-
-
Dec 1987
-$37.60M(+84.4%)
-
-
Dec 1986
-$241.60M(-12.2%)
-
-
Dec 1985
-$215.30M(+15.3%)
-
-
Dec 1984
-$254.20M(-40.1%)
-
-
Dec 1983
-$181.40M(+1.5%)
-
-
Dec 1982
-$184.10M(-26.4%)
-
-
Dec 1981
-$145.60M(-16.2%)
-
-
Dec 1980
-$125.30M
-
-

FAQ

  • What is Bristol-Myers Squibb Company annual cash from investing?
  • What is the all-time high annual cash from investing for Bristol-Myers Squibb Company?
  • What is Bristol-Myers Squibb Company annual cash from investing year-on-year change?
  • What is Bristol-Myers Squibb Company quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Bristol-Myers Squibb Company?
  • What is Bristol-Myers Squibb Company quarterly cash from investing year-on-year change?
  • What is Bristol-Myers Squibb Company TTM cash from investing?
  • What is the all-time high TTM cash from investing for Bristol-Myers Squibb Company?
  • What is Bristol-Myers Squibb Company TTM cash from investing year-on-year change?

What is Bristol-Myers Squibb Company annual cash from investing?

The current annual cash from investing of BMY is -$21.35B

What is the all-time high annual cash from investing for Bristol-Myers Squibb Company?

Bristol-Myers Squibb Company all-time high annual cash from investing is $5.08B

What is Bristol-Myers Squibb Company annual cash from investing year-on-year change?

Over the past year, BMY annual cash from investing has changed by -$19.06B (-830.37%)

What is Bristol-Myers Squibb Company quarterly cash from investing?

The current quarterly cash from investing of BMY is -$473.00M

What is the all-time high quarterly cash from investing for Bristol-Myers Squibb Company?

Bristol-Myers Squibb Company all-time high quarterly cash from investing is $3.96B

What is Bristol-Myers Squibb Company quarterly cash from investing year-on-year change?

Over the past year, BMY quarterly cash from investing has changed by +$846.00M (+64.14%)

What is Bristol-Myers Squibb Company TTM cash from investing?

The current TTM cash from investing of BMY is -$1.39B

What is the all-time high TTM cash from investing for Bristol-Myers Squibb Company?

Bristol-Myers Squibb Company all-time high TTM cash from investing is $5.08B

What is Bristol-Myers Squibb Company TTM cash from investing year-on-year change?

Over the past year, BMY TTM cash from investing has changed by +$21.31B (+93.89%)
On this page